Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing
Reexamination Certificate
2009-06-30
2011-12-20
Carlson, Karen (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C530S350000
Reexamination Certificate
active
08080515
ABSTRACT:
The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
REFERENCES:
patent: 5721213 (1998-02-01), Sato et al.
patent: 6140072 (2000-10-01), Ferrari et al.
patent: 6146824 (2000-11-01), Bar-Shavit
patent: 6992172 (2006-01-01), Chang et al.
patent: 7517954 (2009-04-01), Bouwstra et al.
patent: 7560427 (2009-07-01), Bouwstra et al.
patent: 7598347 (2009-10-01), Bouwstra et al.
patent: 7645737 (2010-01-01), Bouwstra et al.
patent: 7671016 (2010-03-01), Bouwstra et al.
patent: WO 98/18918 (1998-05-01), None
patent: WO 02/064625 (2002-08-01), None
International Search Report of PCT/NL2004/00208 dated Feb. 16, 2005.
Wierzba et al., “Production and Properties fo a Bifunctional Fusion . . . ”, Biotechnology and Bioengineering . . . , Jul. 20, 1995, vol. 47, pp. 147-154, John Wiley & Sons, New York,US.
Zhao et al., Synthesis of RGD containing peptides and their bioactivities. Preparative Biochemistry & Biotechnology 32(4): 2002, 363-3890.
Oku et al., “Liposomal Arg-Gly-Asp analogs effectively inhibit metastatic B16 melanoma colonization in murine lungs.”, Life Sciences, 1996, 58(24): 2263-2270.
Bouwstra Jan Bastiaan
Toda Yuzo
Van Es Andries Johannes Jozef
Carlson Karen
Fuji Film Manufacturing Europe B.V.
K&L Gates LLP
LandOfFree
Method for prevention of platelet aggregation employing and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for prevention of platelet aggregation employing and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prevention of platelet aggregation employing and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262784